- Mission
The mission of the Division of Drug Delivery Technology is to provide new strategies for the delivery of biologically active compounds at the right dose, at the right time and at the right place. In order to achieve this, novel drug delivery systems are designed and the interactions of these delivery systems with biological systems are investigated at the (sub) cellular, tissue and organism level, both in vitro and in vivo. Currently the division focuses on three major research themes:
- Transdermal and dermal drug delivery
- Nasal and (epi) dermal vaccine delivery
- Unwanted immunogenicity of therapeutic proteins
Introduction
Highlights
- Prof. Wim Jiskoot (DDT) the most famous JPharmSci author
The Journal of Pharmaceutical Sciences lists the top-ten most downloaded papers for papers published each quarter of the year. In the most recent listing for January - March 2012 issues, three papers from Prof. Wim Jiskoot, all of which were published in the March 2012 issue, were among the top-ten.
- Read more
- STW project on protein microencapsulation awarded to Wim Jiskoot
-
The project “Controlled release of protein pharmaceuticals from biodegradable, hydrophilic microcapsules produced by supercritical fluid processing” has been granted to Prof. Wim Jiskoot (Division of Drug Delivery Technology) and co-applicant Prof. Geert-Jan Witkamp (section Process Equipment, TU Delft) by STW (Open Technology Programme).
- Read more
- Prof Joke Bouwstra of the Division of Drug Delivery Technology (LACDR) won the prestigious C.E.R.I.E.S. Award.
-
The CE.R.I.E.S. Research Award is intended to honour a researcher with a proven track record in fundamental or clinical research, especially in the physiology and biology of healthy skin, but also on the responses of the skin to the environment. The C.E.R.I.E.S. Award of € 40.000 will be used for future research.
- Read more
